Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Antidiabetic Agents vs Insulin in Hospitalized Type 2 Diabetes Patients
NCT04416269Phase 4Terminated
- Sponsor
- Emory University
- Start
- Aug 2020
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Emory University. Primary endpoint: Mean Daily Blood Glucose Concentration up to 10 days. Started Aug 2020; status: terminated.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04416269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416269.